Skip to main content
Premium Trial:

Request an Annual Quote

Oligo Manufacturer DNA Script Raises €11M in Series A Round

NEW YORK (GenomeWeb) – French synthetic DNA manufacturer DNA Script announced today that it has raised €11 million ($13.1 million) in a Series A financing round.

The round was led by Illumina Ventures — which has received a seat on DNA Script's board — and included investments from Merck KGaA's M Ventures, Sofinnova Partners, Kurma Partners, and Idinvest Partners.

DNA Script said that the funding will be used to advance its enzymatic technology and nucleotide chemistry platform in order to manufacture oligonucleotides more quickly and at lower cost than existing approaches.

"Our new process broadly enables new applications for synthetic DNA and RNA in drug discovery and development, industrial and food technologies, and DNA data storage," DNA Script Cofounder and CEO Thomas Ybert said in a statement. "By applying high-quality oligo synthesis, we believe we can dramatically improve de novo nucleic acid synthesis performance compared to current technologies."

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.